Long-term use: Clinical trials only ran 12 weeks, so long-term safety data (6+ months continuous use) comes from anecdotal reports
Tirzepatide controls blood sugar by stimulating insulin release, lowering glucagon levels and regulating appetite and energy metabolism for weight management
Unwanted facial hair growth (hypertrichosis) occurs more frequently in women, even with proper application technique, resulting from systemic absorption affecting facial follicles
For wellness purposes in non-deficient individuals, there is no universally agreed-upon schedule, and more frequent injections are not necessarily better
Especially for those with inherited obesity or underlying conditions that cause weight gain
Hematocrit and reticulocyte counts should be repeated daily from the 5th to 7th days of therapy and then frequently until the hematocrit is normal